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1. Introduction  
The cardiac arrhythmia is a common cause of morbidity and mortality in the present 
world, especially in developed countries. The etiology of cardiac arrhythmia is quite 
broad involving both hereditary and secondary backgrounds. An increasing number of 
rare but lethal arrhythmogenic mutations have been identified by genome-wide 
association assays in genes associated with cardiac excitation, conduction and 
morphogenesis. Such well-characterized examples include causative mutations in voltage-
dependent Na+, Ca2+ or K+ channel (Nav, Cav, Kv) genes for the prolongation of QT 
interval which sometimes result in premature sudden death and may act as predisposing 
factors to drug-induced arrhythmia (Chen et al., 1998; Roden, 2004; Saenen & Vrints, 2008; 
Towbin & Vatta, 2001; Zareba et al., 2004). Furthermore, some of heart malformations (e.g. 
atrial septal defect) and idiopathic cardiomyopathy (e.g. dilated cardiomyopathy) with 
symptoms of arrhythmias have also proved to have some genetic linkage to impaired 
impulse conduction (Benson et al., 1999; Bonne, et al.,2001; Schott et al., 1998). However, 
much more prevalent are rhythm disturbances and conduction failures occurring in 
‘remodeling’ hearts which progressively undergo structural and electrical changes in 
prolonged metabolically and mechanically stressed states, e.g. chronic heart failure and 
myocardial infarction (Nattel, 2007; Olson, 2005). The well-known consequences of 
cardiac remodeling are; altered expression and gating properties of ion channels shaping 
the action potential and generating pace-making activities; reduced electrical coupling 
which leads to aberrant conduction of excitation. These changes are thought to work as 
the ‘substrates’ increasing the risk of lethal cardiac arrhythmia (Janse, 2004; Nattel, 2007). 
It has also been known that abnormal handling of intracellular Ca2+ occurring in the 
remodeled heart may cause spontaneous membrane depolarizations triggering ectopic 
excitations (Dobrev, 2010; Janse, 2004; Nattel, 2007). However, the available knowledge is 
still limited largely to ion channels/transporters/pumps whose roles in the cardiac 
excitation-contraction cycle have relatively been well established.  
The transient receptor potential (TRP) channels constitute a newly-emerging non-selective 
cation channel (NSCC) superfamily activated by a plethora of physico-chemical stimuli 
other than voltage change. Because of this unique activation profile as well as the ability to 
permeate Ca2+ (except for TRPM4/TRPM5), TRP channels have attracted great attention as 
promising candidate molecules elucidating a variety of biological functions and disorders 
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associated with slow sustained Ca2+ influx initiated by neurohormonal factors, pheromones, 
mechanical (membrane stretch/bending, osmotic change, shear force etc.) and thermal 
(from cold through cool and warm to heat) stresses, noxious stimuli (acid, respiratory 
irritants and toxicants) and many gustatory and pungent/cooling agents (camphor, citral, 
capsaicin, eucalyptol, icilin, menthol, allicin, mustard oil, sweet, umami and bitter tastants 
etc.) (Holzer, 2011; Vay et al., 2011; Wu et al., 2010). In the cardiovascular system, recent 
investigations have revealed pathophysiological implications of TRP channels in vasospasm, 
hypertension, occlusive vascular diseases, cardiac hypertrophy, cardiomyopathy and 
cardiac arrhythmia (Dietrich et al., 2010; Inoue et al, 2009b; Watanabe et al., 2008). 
Especially, as will be described below, involvement of some TRP channels in abnormal 
intracellular Ca2+ handling and increased responses to mechanical and noxious stresses may 
make them particularly relevant to the pathogenesis of acquired cardiac arrhythmias tightly 
associated with cardiac hypertrophy and failure, myocardial infarction and atrial fibrillation 
(Nattel, 2007; Ter Keurs & Boyden, 2007).  
This chapter will deal with the arrhythmogenic potential of several TRP isoforms identified 
in the cardiovascular system, with brief introduction to the general concepts of cardiac 
arrhythmia and its connection to cardiac diseases and with several examples in which the 
roles of TRP channels have been established or suggested.  
2. Factors contributing to cardiac arrhythmia 
 Cardiac arrhythmia is the abnormality of cardiac rhythm, the highly coordinated and 
integrated electrophysiological behavior of multiple ion channels/transporters/exchangers 
residing in tens of billions of myocytes and non-myoctes consisting of the heart. Clinically, 
cardiac arrhythmia can be defined as any anomalous excitations out of normal sinus control, 
and is conventionally classified into bradyarrhythmia (<50 beats per minute) and 
tachyarrhythmia (>100). Faulty or abnormal excitation of sinus node and various extents of 
conduction blocks mainly explain the former. In contrast, ectopic excitations occurring 
outside the sinus node (triggered activity, ectopic automaticity) and perpetuation of 
spiral/scroll waves rotating around a central core/filament (reentry) are thought to 
contribute to the latter. Although the mechanism remains still incompletely understood, 
shortened refractoriness, slowed and anisotropic conduction facilitate the occurrence of 
reentry (Jalife, 2000). Thus, altered expression or activities of ion channels contributing to 
the upstroke (Nav) and repolarization of action potential (Kv) as well as those determining 
the conduction velocity and cell-to-cell coupling [Nav and connexins (Cx), respectively] are 
involved in the reentrant mechanism.  
Ectopic excitations result from premature depolarizations before the next normal 
excitation arrives. Early afterdepolarization (EAD) occurs before the repolarization of 
action potential completely terminates, thereby prolonging it and evoking premature 
action potentials due to re-opening of Nav and/or Cav channels. This is a mechanistic 
background for the initiation of a specific form of polymorphic ventricular arrhythmias 
(Torsades de pointes) observed in both congenital and drug-induced Long QT syndromes; 
the function of ‘repolarization reserve’, i.e. Kv channels, is compromised, or residual 
activity of Nav channel sustains because of its incomplete inactivation (Roberts & Gollob, 
2010).  
Delayed afterdepolarization (DAD) is thought to reflect the generation of transient inward 
currents (Iti) activated by diastolic Ca2+ release from the sarcoplasmic reticulum (SR) of 
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myocytes (Venetucci et al., 2008). If the magnitude of DAD exceeds the threshold of Nav 
channel activation, an extrasystolic discharge of action potentials occurs. Sustained 
discharges from one or more foci may propagate around to cause tachyarrhythmias (focal 
excitation). In ventricular myocytes from rabbit failing heart which shows spontaneous 
ventricular tachyarrhythima, Iti has been ascribed exclusively to enhanced forward-mode 
Na+/Ca2+ exchanger type 1 (NCX1) current (Pogwizd et al., 2001; Pogwizd & Bers, 2004). 
However, there is evidence that implicates Ca2+-dependent Cl- and nonselective cationic 
conductances in the genesis of DAD (Han & Ferrier, 1992; Hill et al., 1988; Kass et a., 1978; 
Laflamme & Becker, 1996; Wu & Anderson, 2000). The mechanism underlying the 
diastolic Ca2+ release is likely to reflect Ca2+ overload into the sarcoplasmic reticulum (SR) 
caused by a net increase in Ca2+ uptake into the SR (increased Ca2+ influx and SRECA2a 
Ca2+-ATPase activity), or the dysfunction of ryanodine type 2 receptor (RyR2) which may, 
especially when intensively phosphorylated by protein kinase A (Wehrens et al., 2003) or 
Ca2+/calmodulin-dependent kinase II (Ai et al, 2005), causes a diastolic Ca2+ leak from the 
SR (Bers, 2006). Thus, under excessive sympathetic activities (hard exercise, mental stress, 
chronic heart diseases) or upon the application of drugs increasing the cAMP level 
(caffeine, catecholamines, phosphodiesterase inhibitors) or [Na+]i (digitalis) in 
cardiomyocytes which increase Ca2+ loading into the SR, the occurrence of DAD and 
resultant tachyarrhythmias may be greatly enhanced (Pogwizd, 2003; Sipido, 2007; 
Venetucci, 2008). In addition, in some pathological settings such as unphysiologically 
decreased extracellular K+ level and excessive sympathetic activity, ectopic automaticity, 
particularly in the Purkinje fiber, can also be abnormally increased to cause 
tachyarrhythmias (Osadchii, 2010).  
Clinical significance of mechanical loading in inducing arrhythmia has been well recognized 
(Dean & Lab, 1989). It is widely accepted that both acute and chronic stretch of myocardial 
tissue significantly affects its electrophysiological properties to increase the propensity for 
arrhythmia (Janse, 2003; Ravens, 2003). Experimentally, a transient diastolic stretch of 
isolated left ventricle was shown to induce ventricular arrhythmia which was inhibited by 
micromolar Gd3+ (Hansen et al. 1991; Stancy et al, 1992). Atrial fibrillation elicited by an acute 
increase in intra-atrial pressure in isolated rabbit hearts was also found effectively blocked 
by MSCC blockers, Gd3+ and a Tarantula toxin GsMTx-4 (Franz and Bode, 2003; Suchyna, 
2000). At the single cell level, Kamkin et al. (2000a) demonstrated that direct stretch of a 
ventricular myocyte could cause membrane depolarization and prolongation of action 
potential resembling EAD, which, at extensive stretch, led to an extrasystolic depolarization. 
This stretch-induced depolarization was attributed to the activation of Gd3+-sensitive 
mechanosensitive NSCCs (MSCCs) (Hamill & Martinac, 2001; Inoue et al., 2009b). The 
stretch sensitivity of MSCCs was significantly enhanced in hypertrophied cardiomyocytes 
with increased susceptibility to stretch-induced arrhythmia (Kamkin et al., 2000a). 
Considering that the heart is continuously subjected to hemodynamic stresses and 
deformation due to contraction, mechanical stresses may play a significant role in the 
causality and severity of arrhythmia, particularly under pressure- and volume-overloaded 
conditions. 
3. Connection of cardiac diseases to cardiac remodeling and arrhythmia 
The cardiac remodeling can be defined as the restructuring and reactivation of differentiated 
cardiac tissues comprised of myocytic and non-myocytic populations, and is initiated and 
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progressed by a complex interplay of genetic, environmental and aging factors (Cohn, et al., 
2000; Fedak, et al., 2005; Swynghedauw, 1999). Chronic heart failure, myocardial infarction 
and atrial fibrillation (AF) are three common pathological states accompanying the 
remodeling process with arrhythmic changes; in which excessively activated sympathetic 
nervous and renin-angiotensin-aldosterone systems, increased generation of inflammatory 
cytokines and reactive oxygen/nitrogen species, and sustained mechanical stresses likely 
play active roles. The remodeling process is initially ‘adaptive’ to compensate the impaired 
pumping function, but gradually becomes ‘maladaptive’ with disturbances in rhythm 
formation and conduction as common clinical complications.  
The key consequences of cardiac remodeling associated with the appearance of arrhythmia 
include both structural and electrical alterations. Enhanced collagen synthesis promotes the 
fibrotic replacement of damaged myocardial tissues thereby increasing the electrical 
heterogeneity. Altered expression and activities of ion channels, transporters and 
exchangers also bring about significant changes in the shape of action potential and its 
conduction properties as well as induce the susceptibility to premature excitations (Nattel, 
et al., 2007; Janse, 2004).  
In chronic heart failure, the major electrophysiological changes are pronounced 
prolongation of action potential which often accompanies EAD-like membrane oscillations. 
These changes likely occur through decreased expression or activity of transient outward 
current (Ito; Kv4,3) and voltage-dependent K+ channels forming the repolarization phase of 
action potential (IKr, IKs) (Bers, 2006; Janse, 2004; Nattel, et al.,2007; Ravens, 2010). The 
reduced inward rectifying K+ current (IK1) may also destabilize the membrane (i.e. increases 
the diastolic membrane resistance) and thereby enhance extrasystolic depolarizing 
responses (DAD) (Nattel, et al., 2007; Pogwitz et al, 2001). Furthermore, upregulation of 
hyperpolarization-activated current (If) and its mRNA (HCN2/4) (Cerbai, 1994; Fernandez-
Velasco et al., 2003) and reduced expression of gap junction channel (Cx43; Dupont et al, 
2001) have been reported to contribute to abnormally enhanced automaticity and impaired 
conduction, respectively. However, more notable changes observed in failing heart are 
abnormalities in intracellular Ca2+ handling (Bers, 2006; Janse, 2004). Despite a reduction in 
the SR Ca2+ content due to decreased expression of SERCA2a, the propensity for triggered 
activity based on DAD is enhanced. This likely reflects the other two major changes in Ca2+ 
handling, i.e. (1) the increased Ca2+ sensitivity of RyR2 under intensive phosphorylation by 
protein kinase A (however controversial now; Wehrens et al, 2003) or Ca2+/calmodulin 
kinase II (Ai et al, 2005) which causes diastolic Ca2+ leak from the SR, and (2) upregulation of 
Na+/Ca2+ exchanger (NCX1) protein which can carry depolarizing inward currents in the 
diastole. It has been suggested that increased ǃ-adrenergic drive, which is prominent in 
chronic heart failure, may greatly facilitate the occurrence of DAD by increasing the Ca2+ 
content in the SR above the threshold of spontaneous Ca2+ release (Bers, 2006; Pogwizd, 
2003).   
Myocardial infarction is initiated by a sudden cessation of blood supply to heart tissues 
(i.e. myocardial ischemia), most frequently by thrombotic obstruction of coronary arteries. 
The time course of ischemic changes in the heart is variable and complex, and can 
mechanistically be distinguished between early and late acute phases, and subsequent 
postinfarction period vulnerable to structural and electrical remodeling (Clements-Jewery 
et al., 2005; Janse & Wit, 1989; Nattel et al., 2007). In acute phases, rapid depletion of 
intracellular ATP and accumulation of intracellular ADP, extracellular K+ and lactate 
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occur because of anaerobic glycolysis, and loss of intracellular K+ and intracellular 
acidosis follows. The extracellular accumulation of K+ leads to the depolarization of 
myocyte membrane that attenuates the amplitude and upstroke velocity of action 
potential (facilitated Nav inactivation) and the shortening of action potential duration 
(due to enhanced Kv activities) or refractoriness. Simultaneously, intercellular 
accumulation and release of many biochemical substances occurs including 
catecholamines, ATP, lysophosphatidylcholine, cytokines (e.g., TNFǂ), reactive oxygen 
species (ROS), and platelet-activating factors (Clements-Jewery et al., 2005; de Jong & 
Dekker, 2010). All these possess arrhythmogenic potential to induce ventricular 
premature excitations (DAD, EAD) and reentry. In postinfarction period, down-regulation 
of K+ channels (Ito, IKs, IKr, IK1) occurs in border-zones adjacent to infarct areas which 
impairs the repolarization of action potential leading to EAD, and altered intracellular 
Ca2+ handling facilitates spontaneous subcellular Ca2+ release events that can trigger 
arrhythmic episodes (Nattel, et al., 2007). 
Atrial fibrillation (AF) is a common supraventicular tachyarrhythmia with rapid and highly 
irregular firing, being closely associated with aging and cardiovascular diseases such as 
heart failure, myocardial infarction, valvular diseases and hypertension (Nattel et al, 2007; 
Ravens, 2010). AF per se is thought to serve as an arrhythmogenic remodeling process, 
because the occurrence of AF itself progressively aggravates electrophysiological features 
and facilitates fibrotic changes of atrial tissues in favor of more frequent and sustained 
occurrences. This clinical feature is described “AF begets AF” and experimentally confirmed 
by the finding that rapid atrial pacing causes significant shortening of atrial refractoriness 
and persistent AF (Wijffels, et al. 1995). The major arrhythmogenic changes found for AF are 
marked shortening of action potential duration which reduces the refractoriness and 
increases the susceptibility to reentry (Nattel et al, 2007; Ravens, 2010). In AF, this change is 
combined with abnormal Ca2+ handling with increased Ca2+ release from the SR and 
augmented NCX1 expression which facilitates ectopic premature depolarizations (i.e. DAD) 
that serve as a trigger to initiate the reentry (Dobrev, 2010). Both reduced/increased or 
unchanged expression of gap-junction channels have been reported, but their increased 
regional heterogeneity may contribute to various extents of conduction failure and reentry 
(Nattel, et al., 2007). 
4. TRP channels and cardiac arrhythmia  
The above considerations strongly suggest that, although alterations in the genesis and 
conduction properties of action potential are undoubtedly of central importance, other 
factors, e.g. Ca2+ overload, increased stretch sensitivity and noxious stimuli generated in 
ischemia/reperfusion, may also play a vital role in arrhythmogenicity. It is also possible that 
structural remodeling (necrotic/apoptotic and fibrotic changes) may contribute to the 
electrical heterogeneity of the myocardium which may act as the pro-arrhythmic substrates 
for altered conduction and reentry. As described above, Ca2+- and stretch-sensitivities, 
nociception as well as association to remodeling are the hallmark features of TRP channel 
members (Inoue et al., 2009b; Nishida & Kurose, 2008; Watanabe et al., 2008; Wu et al, 2010; 
Vay et al., 2011). Therefore, in the following, we would like to discuss about the 
pathophysiological relevance of several TRP isoforms particularly in these aspects of 
acquired arrhythmogenicity (see Table 1). 
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 Intrinsic activator/modulator 
possible arrhythmogenic 
mechanisms 
chemical 
agonists 
inhibitors 
Cardiomyocyte 
TRPC1 
store depletion, stretch?, GPCR 
stimulation (TRPC1/TRPC4 or 
C5), Ca2+/CaM 
strecth-induced 
EAD/DAD in 
hypertrophy? 
 
Gd3+, SKF,  
GsMTX-4? 
TRPC3 
const-act., store depletion, GPCR 
stimulation, BDNF, DAG, 
oxidative stress (TRPC3/C4), 
Ca2+/CaM, PKC, PKG, Src 
oxidative stress? and other 
mediators (ATP, UTP) 
during 
ischemia/reperfusion 
 
Gd3+, La3+, SKF, 
2-APB, flufenamate, 
Pyr-3 
TRPC5 
const-act, store depletion, GPCR 
stimulation, LPC、S1P、EGF, 
neurosteroids, oxdized 
phospholipids, Ca2+/CaM, 
PGE2、S-nitrosylation, 
thioredoxin, oxidative stress 
(H2O2) 
possible relation to 
ischemia/oxidative stress 
in failing heart 
Gd3+, SKF,  
GsMTX-4? 
Gd3+, La3+ (high), 
SKF, 2-APB, BTP-2, 
ML-7, ML-9, 
propfol, halothane, 
chloroform 
TRPC6 
store depletion, stretch?, GPCR 
stimulation, GF, DAG, 20-HETE, 
PIP3/PIP2, Ca2+/CaM, CaMKII, 
PKC, PKG、Fyn 
stretch-inudced 
EAD/DAD in 
hypertrophy? 
flufenamate 
Gd3+, La3+, SKF, 
2-APB, ML-9, ML-7, 
GsMTX-4? 
TRPM2 
oxidative stress (e.g. H2O2), 
ADPR, cADPR, NAADP, AMP, 
[Ca2+]i, pH 
oxidative stress in 
ischemia/reperfusion?  
flufenamate, 
 ACA, 2-APB 
TRPM4 
[Ca2+]i, GPCR stimulation, PIP2, 
MgATP, ATP, ADP, AMP, 
voltage, PKC、CaM, spermine, 
familial conduction block 
(PFHBI, ICCD), stretch-
inudced EAD/DAD?, QT- 
elongation in hypertrophy, 
DAD in AF? 
decavanadate, 
BTP-2 
Gd3+, flufenamate, 
clotrimazol, 9-PA 
cardiac fibroblast 
TRPC6 see above anti-fibrogenesis see above see above 
TRPM7 
const-act, GPCR stimulation, 
[Mg2+]i, MgATP, ATP, CTP, GTP, 
UTP, pH, PIP2, cAMP, PKA, 
spermine, 
fibrogenesis in AF 2-APB (high) Gd
3+, SKF, 2-APB 
(low), LOE908, 
respiratory sensory neuron 
TRPA1 
cold (<17°C), [Ca2+]i, alkalosis, 
stretch, GPCR, PIP2, PKA. autonomic imbalance 
environmental 
irritants 
(acrolein), 
allicin, allyl 
isothocyanate, 
citral, NSAIDs, 
eugenol, 
cinnamaldehyd, 
2-APB,  
GsMTX-4 
HC-030031 
TRPV1 
heat (>43°C)、acidity 
(pH<5.9)、12-HETE, 12-LOX 
metabolites, anandamide, 
chemokines、GPCR (e.g. 
bradykinin, ATP, PAR2)、NGF, 
GDNF, PKA, PKC, PI3K, 
Ca2+/CaM, CaMK II, src, 
calcineurin, Ras/MAPK, SCF 
autonomic imbalance 
enviromental 
irritants, 
capsaicin, 2-
APB、camphor, 
allicin, citral, 
resiniferatoxin, 
gingerol, 
eugenol, EtOH 
capasazeine, 
ABT-102, AMG-517, 
GRC-6211, MK-
2295, SB-366791, 
SB-705498, 
Table 1. Arrhythmogenic TRP channels 
www.intechopen.com
 
The Pathophysiological Implications of TRP Channels in Cardiac Arrhythmia 
 
79 
Abbreviations; CaM, calmodulin: GPCR, G-protein-coupled receptor (Gq-coupled): const-act, 
constitutively active: BDNF, brain-derived neurotrophic factor: DAG, diacylglycerol: PKC, 
protein kinase C: PKG, protein kinase G: LPC, lysophosphatidylcholine: S1P, sphingosin 1-
phosphate: EGF, epidermal growth factor: PGE2, prostaglandin E2: 20-HETE, 20-
hydroxytetraenoic acid: PIP3, phosphatidylinositol 3,4,5-trisphospate: PIP2, phosphatidylinositol 
4,5-trisphospate: CaMKII, calmodulin-dependent kinase II: ADPR, ADP ribose: cADPR, cyclic 
ADP ribose: NAADP, nicotinic acid adenine dinucleotide phosphate: PKA, protein kinase A: 12-
HETE, 12-hydroxy-5,8,10,14-eicosatetraenoic acid: LOX, lipooxygenase: PAR2, Proteinase-
activated receptor 2: NGF, nerve growth factor: GDNF, glial cell-line derived neurotrophic factor: 
MAPK, mitogen-activated protein kinase: SCF, stem cell factor: SKF, SK&F96365: BTP-2, 4-
methyl-4 -[3,5-bis(trifluoromethyl)-1H-pyrazol-1-yl]-1,2,3-thiadiazole-5-carboxanilide: Pyr-2, 
Ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoroluoromethyl)-1H-pyrazole-4-
carboxylate: 2-APB, 2-aminoethoxydiphenyly boroate, 9-PA, 9-phenanthrol. 
4.1 Stretch-induced arrhythmia in pathological settings 
As described above, acute stretch of cardiac muscle can induce arrhythmic responses in both 
atrium and ventricle, which are inhibited by widely used MSCC blockers Gd3+ and GsMTx-
4. This has led to the speculation that activation of nonselective cationic MSCCs causes 
premature depolarizations. There are at least three candidates for these MSCCs in TRPs 
expressed in the heart, i.e. TRPC1, TRPC6 and TRPM4.  
In both heterologous and native overexpression systems, TRPC1 and TRPC6 have been 
found to activate in response to mechanical stimuli (Maroto et al.,2005; Spassova et al., 2006). 
Albeit controversial (e.g. Inoue et al., 2009a), the so-called MSCC-selective peptide blocker 
GsMTx-4 has been found to inhibit the mechanical activation of both TRPC1- and TRPC6-
mediated MSCC activities (Maroto et al.,2005; Spassova et al., 2006). TRPC1 and TRPC6 are 
ubiquitously expressed in whole myocardial tissues (Huang et al, 2009; Ward et al., 2008), 
and GsMTx-4 suppresses stretch-induced force development and concomitant [Ca2+]i 
increase in mouse left ventricular trabecular muscle (Ward et al., 2008) and pressure-
induced atrial fibrillation (Franz and Bode, 2003). Moreover, the expression of TRPC1 and 
TRPC6 is greatly increased in hypertrophied heart under prolonged pressure overload 
(Kuwahara, et al; 2006; Ohba, et al., 2007), where the susceptibility to mechanically-induced 
arrhythmia is also enhanced (Kamkin et al., 2000a). All these observations favor the view 
that TRPC1 and TRPC6 contribute to stretch-induced arrhythmias as MSCCs in some 
pathological settings. However, there is controversy over the mechanosensitivity of these 
two TRPC channels. In knock-out mice deficient in TRPC1 or TRPC6 expression, pressure-
induced vasoconstriction (myogenic response), which is believed to reflect the depolarizing 
effects of MSCC activation, was found intact (Dietrich et al., 2005; Gottlieb et al., 2007). 
Although this fact could not totally negate the roles of these TRP channels in the heart, it is 
essential to test whether mechanical activation of myocardial MSCCs and mechanical 
arrhythmogenicity are indeed impaired in these knock-out mice or vice versa in TRPC1- or 
TRPC6-overexpressing mice. Alternatively, it may also deserve to test the possible 
involvement of a recently identified GsMTx-4-sensitive MSCC, Piezo1/Piezo2, in stretch-
induced arrhythmia in the heart (Bae et al., 2011). 
In cerebral arterial myocytes, TRPM4 has been proposed as a MSCC responsible for 
myogenic response (Earley et al., 2004). However, again, the results from TRPM4-deficient 
mice do not support this role (for more detail, see below) (Mathar et al., 2010). Nevertheless, 
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it is noteworthy that TRPM4 can be secondarily activated by mechanical stretch through 
stretch-induced Ca2+ release from ryanodine-sensitive stores in arterial myocytes (Morita et 
al., 2007), since similar axial stretch-induced Ca2+ release from the SR has been demonstrated 
in cardiomyocytes (Iribe, et al., 2009). Considering that heart wall is periodically distended 
by diastolic filling pressure, this mechanosensitive mechanism may have considerable 
pathophysiological significance for the genesis of DAD in remodeled heart in which the 
expression of TRPM4 and Ca2+ loading into SR are prominently enhanced (see below).  
It has been shown that repeated cyclic stretch induces hypertrophic responses of cardiac 
myocytes, which are significantly attenuated by antagonists for a PLC-linked G-protein 
coupled receptor (GPCR), angiotensin type 1 (AT1) receptor (Komuro and Yazaki, 1993). 
This is explained by direct mechanical activation of unoccupied AT1 receptor as 
demonstrated by the substituted cysteine accessibility mapping technique (Yasuda et al., 
2008). Similar mechanical activation also appears to occur for many other PLC-linked 
GPCRs including endothelin ETA, vasopressin V1A and muscarinic M5 receptors (Mederos y 
Schnitzler et al., 2008). TRPC6 and its homologue TRPC3 are activated by stimulation of 
PLC-coupled GPCRs via generation of diacylglycerol (DAG) (Hofmann, et al., 1999) and 
Ca2+ influx through activated TRPC3 and TRPC6 channels has been shown to be essential 
for hypertrophic responses of caridomyocyte via calcineurin/NFAT pathway (Kuwahra et 
al., 2006; Bush et al., 2006; Onohara et al., 2006). In failing hearts where pressure overload is 
sustained, the release of catecholamines from sympathetic nerves and adrenal gland is 
increased (see above), and the production of angiotensin II (AngII) and expression of AT1 
receptor and angiotensin converting enzyme are greatly enhanced (Goette, A et al., 2000; 
Ihara M et al, 2000; Kaprielian RR et al., 1997). Moreover, the mechanosensitivity of TRPC6 
channel is remarkably enhanced by the simultaneous stimulation of PLC-linked GPCRs via 
concerted actions of two lipid messengers DAG and 20-HETE (Inoue et al., 2009a). Thus, 
taken together, it is highly conceivable that sustained mechanical loads promote the 
hypertrophic remodeling of cardiomyocytes through synergistic interplay between 
excessive activation of GPCR-PLC pathways and enhanced receptor/mechanical activation 
of TRPC6 (and TRPC3) channels. This would in turn exacerbate Ca2+ overload into the 
myocyte SR to increase the propensity for pro-arrhythmic depolarizations. Consistent with 
this scenario, cardiac-specific TRPC6 transgenic mice have been found to exhibit much 
increased susceptibility to mechanical stress with increased incidence of sudden death 
accompanied by severe macroscopic and histological signs of cardiomyopathy (Kuwahara et 
al., 2006). The same study also found that expression of TRPC6 was several-fold upregulated 
in human failing heart. Obviously, detailed electrophysiological analyses are required to 
corroborate whether the above changes could indeed induce the arrhythmogenicity. 
4.2 Ca
2+
-dependent arrhythmia 
Abnormal Ca2+ handling or cycling in cardiac tissues is the main cause for arrhythmia (Ter 
Keurs & Boyden, 2007). As briefly introduced above, diastolic Ca2+ release (or leak) from the 
SR is a key event to initiate arrhythmogenic premature depolarizations DAD. Presently, the 
mechanism whereby DAD is generated by the Ca2+ release can be accounted for by the 
activation of three ionic conductances which can generate Iti near the resting membrane 
potential; an electrogenic forward-mode NCX1 current which allows the influx of three Na+ 
ions in exchange of one Ca2+ efflux after the repolarization has completed; and Ca2+-
activated Cl- and nonselective cation channel (CAN) currents. Although the most accepted 
hypothesis suggests that Iti is carried exclusively by enhanced forward-mode NCX1 inward 
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current in failing ventricle (Pogwizd, et al. 2001; Pogwizd, 2003; Wu and Anderson, 1999), 
there is also experimental evidence suggesting the involvement of Ca2+-activated Cl- current 
(Han et al., 1996; Laflamme et al., 1996) and CAN (Hill et al., 1988; Kass et a., 1978; Wu & 
Anderson, 2000) in the genesis of Iti.  
CAN constitutes a large heterogenous family of cation channels with varying unitary 
conductances, Ca2+-sensitivities, voltage dependence and regulations, and distributes 
broadly in neurons, smooth muscle, heart, exocrine and endocrine glands, and other 
epithelial tissues (Siemen, 1993). The most frequently recorded CAN from cardiac tissues, 
first identified in a cultured rat neonatal ventricular myocyte (Colquhoun, 1981), is a 20-
40pS channel with almost equal selectivity over monovalent cations and poor permeability 
to divalent cations (Guinamard et al, 2006). Albeit rather great variations, these cardiac 
CANs are activated by the micro- to mili-molar range of Ca2+ and voltage-dependent. The 
molecular identification that best fits this type of CAN is now thought to be TRPM4 protein 
(Launay et al., 2002). Expressed TRPM4 channel shows a ~25pS conductance (in near-
physiological ionic milieu), is monovalent cation-selective, and, in cell-free conditions, 
undergoes Ca2+-dependent activation and depolarization-dependent enhancement of open 
probability only in their unphysiologically high ranges. However, it has been found that the 
Ca2+- and voltage-sensitivities of TRPM4 rapidly shift to their much higher ranges 
immediately after the excision of patch membrane (‘desensitization’ or ‘rundown’), and this 
is substantially prevented by pretreatment with MgATP, protein kinase C activators, 
maneuvers replenishing phosphatidylinositol 4,5-bisphosphate and increased temperature 
(Nilius, 2006). These findings suggest that, in vivo, TRPM4 may be more effectively 
regulated by physiological ranges of [Ca2+]i and membrane potential. Expressed TRPM4 
channel also undergoes negative regulation of free adenosine nucleotide phosphates 
(efficacy; ADP > ATP = AMP), and is subject to spermine block, so that severe ischemic 
conditions might affect this channel activity (Nilius et al., 2004).  
In human, cardiac expression of TRPM4 is ubiquitous in the order of abundance; Purkinje 
fibers, septum, atrium, left and right ventricles (Kruse et al., 2009). Guinamard et al (2002) 
found that expression of TRPM4-like CAN, which was virtually absent at the time of cell 
isolation, was progressively enhanced in rat dedifferentiating ventricular myocytes with the 
time of culture. Studies from the same group also found that purinergic receptor activation by 
ATPǄS, PKC activators and DAG, all of which act as interventions to facilitate cardiac 
remodeling, enhanced the occurrence of TRPM4-like channel in cultured ventricular myocytes. 
This led to the postulation that remodeling of ventricular myocytes in response to excessive 
hypertrophic signals may enhance the activity of TRPM4 thereby increasing arrhythmogenic 
propensity mostly likely by increasing DAD. Consistent with this, in the hypertrophic heart of 
spontaneously hypertensive rat, the elongation of Q-T interval in electrocardiogram has been 
reported together with increased expression of TRPM4 protein and density of CAN 
(Guinamard et al., 2006). Recent reports indicate that TRPM4 is more abundantly expressed in 
atrium and sinoatrial node (Demion et al, 2007; Guinamard, 2004; Kruse et al., 2009), where 
DAD-based tachyarrhythmias have been well established (Dobrev, 2010; Guinamard 2006; 
Nattel 2007; Raves, 2010). However, TRPM4-deficient mice showed no obvious abnormalities 
in heart rate, cardiac output, ejection fraction and cardiac contractility at basal conditions 
questioning a vital role of TRPM4 in physiological regulation of cardiac functions (Mathar et 
al., 2009). Rather unexpectedly, the genetic deletion of TRPM4 caused postnatal development 
of high blood pressure due to increased sympathetic catecholamine secretion. These seemingly 
paradoxical observations might point to the pathological contribution of TRPM4 to 
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arrhythmogenicity in diseased remodeling heart rather than to normal rhythm formation, in 
which the expression and activity of TRPM4 are enhanced.  
A recent genetic analysis of human families with lethal conduction failure has found a gain-
of-function mutation (c.19G→A in exon 1 or p.E7K) in the N-terminal domain of TRPM4 
channel (PFHBI; progressive familial heart block type I) (Kruse et al., 2009). More recently, 
other TRPM4 mutations with very similar biological impacts (p.R164W, p.A432T, p.G844D) 
have also been assigned to autosomal dominant isolated cardiac conduction block (ICCD) of 
Lebanese and French families (Liu et al., 2010). Biochemical and immunocytochemical data 
suggested that these mutations increase the cell surface expression of TRPM4 protein due to 
desregulated SUMOylation/deSUMOylation process which results in impaired endocytotic 
protein degradation. The accompanying electrophysiological changes for these mutations 
are consistent with the biochemical/immunicytochemical data; the density of whole-cell 
CAN current was increased with little noticeable changes in macroscopic Ca2+ sensitivity 
and voltage dependence or in unitary conductance and open probability at single channel 
level. These results suggest that the number of functional channels were increased without 
altered biophysical properties. The precise pathogenic mechanism for these mutations to 
cause conduction block remains unclear. However, RT-PCR analysis indicated the highest 
expression of TRPM4 in Purkinje fiber, and detailed immunohistochemical examination 
showed strongly TRPM4-positive subendocardial bundles of Purkinje fibers branching and 
penetrating toward subepithelial layer (Kruse et al., 2009; Liu et al., 2010). These 
morphological findings, combined with a broadened QRS complex in ECG in both PFHBI 
and ICCD patients, led the authors to speculate that elevated TRPM4 expression may 
increase the membrane leak conductance thereby disabling action potential propagation 
along the Purkinje fibers. There are several previous studies showing that Ca2+ overload 
causes membrane oscillations in Purkinje fibers due to increased spontaneous Ca2+ release 
when Na+ extrusion via Na+/K+-ATPase was pharmacologically inhibited (Kass et al., 1978; 
Kass & Tsien, 1982; Lederer & Tsien, 1976). Considering that TRPM4 may also act as a Na+ 
entry pathway in response to GPCR stimulation (Launay, et al., 2002), the resultant increase 
in [Na+]i might then elevate [Ca2+]i via the reversed mode operation of NCX1 in Purkinje 
fiber cells (Bers, 2006; Pogwizd, 2003). This would not only facilitate Ca2+ overload and DAD 
generation due to increased TRPM4 channel activation, but could also induce cell death 
leading to cardiac injury/remodeling if the elevation of [Ca2+] would persist. Fibrotic 
replacement observed in the His-Purkinje fiber system of a PFHBI patient (Kruse et al., 2009) 
may support the latter possibility. Thus, the depolarizing and Na+-permeating properties of 
TRPM4 channel could bring about both acute (induction of DAD) and chronic (conduction 
block due to remodeling) pro-arrhythmic effects. 
4.3 Arrhythmia associated with ischemia and oxidative stress  
In the acute phases of myocardial infarction, many arrhythmogenic substances are released 
(see above). ATP and UTP are amongst these, being released from cardiomycytes during 
ischemia and may promote the occurrence of ventricular tachyarrhythmias (Dutta et al., 
2004; Kuzmin et al., 1998). In vitro, ATP can induce DAD-based arrhythmic depolarizations 
in single cadiomyocytes when combined with Ca2+ increasing agents such as catecholamines 
(Song & Belardinelli, 1994). In voltage-clamped adult ventricular myocytes, ATP/UTP can 
activate a sustained inward current via P2Y2 receptor and enhance the opening of 14 and 
23pS single channel activities in a PLC-dependent manner. TRPC3 and TRPC7 proteins from 
rat ventricular myocytes immunocoprecipitated, and the macroscopic current induced by 
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ATP was suppressed by intracellular application of anti-TRPC3 antibody from the patch 
pipette (Alvarez et al., 2008). These findings are collectively interpreted as indicating that 
ATP/UTP may cause arrhythmia by activating TRPC3/TRPC7 heterotetrameric Ca2+ and 
Na+ entry channels whereby to facilitate intracellular Ca2+ overloading and trigger electrical 
activities. Consistent with this scenario, the same researchers’ group has recently shown that 
flash photolysis of caged ATP can evoke one or even a train of extrasystolic contractions. 
Further, intraperitoneal injection of creatine, which is capable of buffering a sudden 
ATP/UTP release and clinically exhibits anti-arrhythmic effects, markedly reduced 
ventricular tachyarrhythmias and early death events in a rat coronary-ligature myocardial 
infarction model. These ameliorating effects of creatine were defective in an inactive creatine 
analogue ǃ-guanidinopropionate (Vassort et al., 2010). Cell surface expression of TRPC3 was 
found tightly controlled by vesicular trafficking, cytoskeletal actin dynamics and interaction 
with caveolar or subsarcolemmal proteins and molecules (Groschner K, et al., 2005). And 
PLC stimulation by AngII in cardiomycytes was reported to facilitate the recruitment of 
TRPC3 complexed with NCX1 to cell membrane, resulting in the reverse mode Ca2+ entry 
through NCX1 (Eder et al., 2007). Thus, although the precise connection between TRPC3 
(and possibly TRPC7) channel activation by ATP and arrhythmogenicty is unclear, the 
above mechanism may have particular pathophysiological significance in Ca2+-dependent 
arrhythmogenesis during postinfaction remodeling period or sudden ischemic insult of 
hypertrophied heart, where enhanced expression of TRPC3 and sympathetic nerve activity 
play pivotal roles. Seemingly in line with these results, a recent independent study has 
reported that cardiomyocytes from TRPC3-overexressing mice show an increased 
susceptibility to apoptotic death due to Ca2+ overload when subjected to 
hypoxia/reoxgenation (Shan et al., 2007).  
Oxidative stress causes tissue damage in a variety of pathological states including aging, 
cancer, neurogenerative disorders, autoimmune diseases, atherosclerosis and 
ischemia/reperfusion injury of myocardium (Chandra et al., 2000; Langley et al., 2004; Misra 
et al., 2009). Many reactive oxygen spices (ROS; O2-·,·OH, H2O2, NO, ·ONOO-) are generated 
as the result of ischemia and reoxygenation and may confer the susceptibility to arrhythmia 
in direct and indirect ways (via modifying autonomic nerve activity (Danson et al., 2006; 
Misra et al., 2009). Several TRP members including TRPM2, TRPM7, TRPC5 and a 
TRPC3/TRPC4 heterooligomer are known to be activated by oxidative stresses (Miller & 
Zhang, 2011; Naylor et al., 2011; Poteser et al., 2006). TRPM2 is the first reported ROS-
sensitive Ca2+-permeable nonselective cation channel activated by H2O2, ADP-ribose, TNFǂ, 
and ǃ-amyloid peptide, and is implicated in both physiological functions and 
pathophysiology including oxidant (H2O2)-induced cell damage/death in pancreatic ǃ-cells 
and neurons. TRPM2 is positively regulated by intracellular Ca2+, and its cell damaging 
action appears to be mediated at least in part by sustained [Ca2+]i elevation (Takahashi et al., 
2011). In myocardial infarction, reperfusion injury and congestive heart failure, elevated 
plasma levels of TNFǂ have been reported (Sack et al., 2000). TNFǂ can activate both 
cytotoxic and cytoprotective signaling pathways in many cell types including mitochondrial 
ROS production through the recruitment of caspase-8 into the death-inducing signaling 
complex (Kroemer et al., 2007; Zhu et al., 2006). Further, altered redox state changes the 
activity of cardiac ion channels and transporters regulating Ca2+ dynamics in the 
cardiomyocyte, i.e. L-type Cav, RyR2, NCX1 and SERCA2a (Zima & Blatter, 2006). In 
keeping with these observations, activation of TRPM2 by oxidative stress (H2O2) has been 
found to cause apoptotic/necrotic changes in single cardiomyocytes with ultrastructural 
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changes characteristic of cardiac ischemia/reperfusion injury (Yang et al, 2006). Although 
whether these changes are pro-arrhythmic remains to be explored, it is possible that 
sustained [Ca2+]i elevation through activated TRPM2 channel would disturb basal Ca2+ 
homeostasis underlying rhythmic excitations in cardiomyocytes thereby inducing Ca2+-
dependent arrhythmogenicity. The arrhythmogenic effect of TRPM2 may not necessarily be 
restricted to direct cell-damaging actions via sustained [Ca2+]i elevation. It could occur 
indirectly through the production of inflammatory cytokines from ambient immune cells, as 
was demonstrated in an animal model of inflammatory bowel syndrome (Yamamoto et al., 
2008).  
In addition, expression of TRPC4 and TRPC5 was found to increase 2-3-fold in cultured rat 
cardiomyocytes subjected to downregulation of SERCA by siRNA technology which mimics 
the remodeling process of diseased heart (Seth et al., 2004). TRPC5 is known to be activated 
by many noxious stimuli such as H2O2 and LPC (Flemming et al., 2006; Naylor et al., 2011), 
and thus could act as a pro-arrhythmic mediator in ischemic remodeling heart. This 
possibility will be an intriguing subject of future investigation, together with other TRP 
isoforms implicated in the pathogenesis of cardiomyopathy (TRPV2, TRPC7; Iwata et al., 
2003; Satoh et al., 2007). 
4.4 Arrhythmia related to fibrosis 
Cardiac fibroblasts occupy about 70% of whole cardiac cell populations, and, once placed in 
pathological states such as myocardial injury, oxidative stress and excessive mechanical 
stretch, start to proliferate and differentiate into the active phenotype ‘myofibroblast’. 
Activated myofibroblasts secrete extracellular matrix proteins (e.g. collagen), matrix 
metaloproteinases, cytokines and growth factors thereby promoting the pathological 
restructuring of diseased heart with fibrotic replacement of damaged myocardial tissue 
(Souders, et al., 2009). Cardiac fibroblasts have a shallow resting membrane potential (-30 - -
10mV) and are non-excitable themselves, but show mechanically-induced depolarizations 
well synchronized with spontaneous contractions of myocardium (Kamkin et al, 2000b; 
Kamkin et al, 2003). These electrophysiological properties allow them, by coupling 
electrically to myocytes as a leaky capacitor, to modify the electrical properties of myocyte 
action potential and its propagation (Yue et al., 2011). In contrast, fibrotic tissues generated 
by myofibroblasts act as a physical barrier insulating the spread of electrical currents 
between the bundles of cardiomyocytes. Thus, disturbances in the myocyte-fibroblast 
coupling and alterations in myocardial architecture due to spatially inhomogenous fibrosis 
can lead to cardiac arrhythmias associated with reentry or conduction block.  
It has been known that fibrotic remodeling is a fundamental process underlying the 
perpetuation of AF. Atrial fibrosis is dependent on Ca2+, but what source of Ca2+ is involved 
therein had been elusive. A recent study of Du et al. (2010) demonstrated that upregulation 
of TRPM7, a constitutively active Ca2+/Mg2+ entry channel (Wu et al, 2010), and resultant 
Ca2+ influx was crucial for the progression of atrial fibrosis in AF patients. This was 
supported by the following evidence; (1) human atrial fibroblasts express TRPM7 protein 
abundantly, and show basal Ca2+ influx and spontaneously active Ca2+-permeable inward 
currents with the fingerprint features of heterologously expressed TRPM7 channels 
[potentiation by low pH and inhibition/potentiation by low/high concentrations of 2-
aminoethoxydiphenyly boroate (2-APB) respectively: Li et al., 2006, 2007]; (2) TRPM7-like 
current and accompanying Ca2+ influx were strikingly increased in parallel with the 
upregulation of TRPM7 expression in differentiated fibroblasts from AF patients; (3) all 
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these changes were largely eliminated by knockdown of TRPM7 expression with small 
hairpin RNA; and (4) in vitro promotion of myofibroblastic differentiation by TGF-ǃ1, a 
major stimulator of atrial fibrosis, was correlated with the upregulation of TRPM7. 
Although in this study a direct linkage between Ca2+ influx through TRPM7 channel, the 
fibrogenesis and arrhythmogenesis in AF have not been explored, the above results may 
provide a new therapeutic target against the progression of AF, by disclosing an essential 
role of TRPM7-asscociated Ca2+ influx in fibroblast proliferation and differentiation.     
In rat neonatal cardiac fibroblasts, endothelin-1 (ET-1) or AngII can induce myofibroblastic 
differentiation and collagen synthesis via the Gǂ12/13 signaling. ET-1 (via ETA receptor) and 
AngII can also selectively enhance the expression of TRPC6, thereby increasing basal Ca2+ 
influx in the fibroblasts. Importantly, increased TRPC6 expression is causally correlated 
with anti-fibrotic effects via calcineurin/NFAT pathway (Nishida et al., 2007). The 
upregulation of TRPC6 likely occurs through the G12/13- (Rac/NOX)-ROS-JNK signaling, 
which is reminiscent of TRPC6-mediated abnormal proliferation of pulmonary artery 
smooth muscle cells induced by platelet-derived growth factor, a pathogenic model of 
pulmonary artery hypertension (Yu et al., 2003). The concentrations of ET-1 or AngII 
required to upregulate TRPC6 are significantly higher than those for the differentiation of 
fibroblasts (Nishida et al., 2007). Thus, in an intriguing contrast to the pro-fibrotic role of 
TRPM7, the anti-fibrotic effects of enhanced TRPC6 channel activity may serve as a negative 
feedback mechanism to limit excessive fibrogenesis via ET-1/AngII signaling during cardiac 
remodeling. It remains to be determined whether this mechanism works beneficially in 
human AF patients or other fibrosis-associated arrhythmias. 
4.5 Arrhythmia related to autonomic imbalance 
The cardiac rhythm is under tight control of the autonomic nervous system. For instance, 
baroreceptors monitor blood pressure fluctuations and transmit the information to the 
brainstem vasomotor center via parasympathetic afferents, which then modulates the 
cardiac pumping force and rate via sympathetic efferents. The renin-angiotensin-
aldosterone system is another well-established system centrally controlled via sympathetic 
nerves (via ǃ1-adrenoceptor). It fulfills a long-term control of body fluid and electrolyte 
balance, thereby effectively regulating the cardiac output (Guyenet, 2006). Any disturbances 
in these centrally-mediated autonomic regulations could therefore become the substrates for 
cardiac arrhythmias (Danson, et al., 2006; Janse 2004; Nattel, et al., 2007). Accumulating 
evidence however suggests that nociceptive reflexes via respiratory sensory neurons (e.g. C-
fibers in nose and lung) have also some pathophysiological impact on cardiac functions 
through centrally-mediated autonomic mechanisms, as exemplified by air pollutant–
induced changes in ‘repolarization’ parameters of ECG (Henneberger et al., 2005). The 
sensory nerve endings in respiratory airways contain two TRP members sensing noxious 
stimuli, i.e. TRPV1 and TRPA1 which likely participate in airway chemosensation and 
inflammation (Bessac & Jordt, 2008). It has thus been postulated that these TRP isoforms 
may be involved in nociceptive signaling in the respiratory system (Vay et al., 2011).  
Two recent studies have revealed intriguing associations between respiratory sensory TRP 
channels and arrhythmogenicity. In one experimental model, activation of respiratory 
sensory neurons by inhalation of concentrated ambient particles significantly affected the 
cardiac rhythm with decreased heart rate, and shortened QT interval and P wave duration. 
Abrogation of these cardiac effects by a selective TRPV1 antagonist capsazepine suggested 
that TRPV1-mediated autonomic reflexes play a central role therein (Ghelfi et al., 2008). In 
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another study employing a gaseous pollutant (Hazari et al., 2011), one-day exposure of rats 
to diesel exhaust gas resulted in increased heart rate with pro-arrhythmic ECG changes of 
prolonged action potential and shorted repolarization. Notably, these rats showed much 
heightened sensitivity to aconitine challenge that can induce moderate to lethal ventricular 
tachyarrhythmias dose-dependently. This pro-arrhythmic change was prevented by 
pretreatment with a TRPA1 antagonist HC-030031 or by sympathetic blockade with 
guanethidine, suggesting the involvement of increased sympathetic drive. In addition, 
partial involvement of TRPV1 in moderate aconitine-induced tachyarrhythmias was also 
suggested by pharmacological inhibition with a selective TRPV1 antagonist SB-366791. 
Although detailed mechanisms underlying remain unclear, these results clearly point to the 
pro-arrhythmic risk of environmentally-induced autonomic imbalance in which sensory 
chemosensing channels TRPA1 and TRPV1 may play a pivotal role. 
5. Conclusions and therapeutic implications 
The evidence presented above has disclosed that the unique activation profile (e.g. stretch- 
and Ca2+-sensitivities, neurohormonal activation, sensitivity to noxious stimuli) and 
permeability to Ca2+ and Na+ (TRPM4/TRPM5 are however virtually Ca2+-impermeable) 
render several TRP channels contribute to the acquired arrhythmogenesis during cardiac 
remodeling and other pathological processes. The examples so far available implicates, at 
least, TRPC1 and TRPC6 (and possibly their homologues) in stretch-induced arrhythmias in 
both acute and chronic manners, TRPM4 in Ca2+-dependent arrhythmia and familial 
conduction block, TRPC3 and TRPM2 in ischemia-induced arrhythmia, TRPA1 and TRPV1 
in autonomic imbalance-induced arrhythmia, and TRPM7 and TRPC6 in fibrosis-related 
arrhythmogenicity, especially in AF, as pro-fibrotic and anti-fibrotic factors respectively. 
Although the mechanism of the actions of each TRP isoform appears variable in different 
pathophysiological settings, these new lines of evidence have certainly put forward our 
essential understanding about the pathogenesis of commonly observed arrhythmias 
associated with cardiac diseases accompanying structural and electrical remodeling. 
Simultaneously it may open an avenue toward exploiting an entirely new generation of anti-
arrhythmic drugs for increased mechanosensitivity, abnormal Ca2+ handling, oxidative 
stress, or nociception.  
When considering the actual strategy for developing such drugs, however, there are at least 
two not easily tractable problems. The serious lack of structure-based chemical knowledge 
about the selectivity and efficacy for most TRP members is the first obvious one, although 
substantial progress is going on for analgesic therapy based on TRPV1 pharmacology 
(Szallasi et al., 2007). Virtually all drugs so far shown to be effective for cardiovascular TRP 
isoforms appear to be non-specific or have only narrow ranges of concentrations for their 
relatively selective actions, as exemplified by a pyrazole compound Pyr-3 for TRPC3 which 
reportedly inhibits experimentally-induced cardiac hypertrophy (Kiyonaka et al., 2009). The 
second type of difficulty for exploiting TRP-selective drugs is that connecting one TRP 
isoform to one end-function is almost always irrelevant oversimplification. This is because 
signaling pathways linked to TRPs appear to form a complex interwoven network with high 
degrees of divergence and convergence and with numerous feed-back and -forward 
regulations. In addition to this, activation of TRP channels depends intimately on local lipid 
dynamics in the cell membrane, which dramatically changes by lipid composition, voltage, 
temperature, membrane stretch, and enzyme-assisted catalysis (Hardie, 2007; Inoue et al., 
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2009b). In the current absence of good knowledge about lipid physiology/pathophysiology 
for membrane proteins, these disadvantages would make it difficult to pharmacologically 
manipulate the gating of TRP channels. In this context, recent observations that activation of 
the cGMP-PKG signaling by nitric oxide, atrial natriuretic peptides and their structural and 
functional mimetics attenuate hypertrophic cardiac remodeling partly via inhibition of TRP 
channels (Inoue et al., 2010; Tsai & Kass, 2009) may provide a promising alternative 
maneuver to ameliorate the acquired arrhythmogenicity. Activation of this pathway is also 
known to improve myocardial damage after myocardial infarction (Burley et al., 2007; 
Garcia-Dorado et al., 2009). Obviously, there is much to be learned about the pathogenic 
roles and therapeutic potential of cardiovascular TRP channels for cardiac arrhythmias. 
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